Xxxxx, M. D. and Xxxxxx Xxxxxxxx as a condition to the consummation of the transactions contemplated by the Merger Agreement.
Xxxxx, M. D. residing at 0000 Xxxx Xxxxx, Xxx Xxxxx, Xxxxxx 00000, ("ASSIGNOR") to Steroidogenesis Inhibitors International, a corporation organized under the laws of the State of Nevada and having an office at 000 Xxxxxxxxxx Xxxxxx Xxxxx, Xxxxx 000, Xxx Xxxxx, Xxxxxx 00000 ("ASSIGNEE"). FOR ONE U.S. DOLLAR ($1.00) AND FOR OTHER GOOD AND VALUABLE CONSIDERATION, the receipt of which is hereby acknowledged, ASSIGNOR does hereby sell, assign and transfer to ASSIGNEE the entire right, title and interest, together with all rights of priority, in and to my invention entitled CIRCADIAN RHYTHM CORTISOL CHART AND METHODS OF USE, as described and/or claimed in an application for patent of the United States of America, Serial No. ________. A declaration for the application has been executed on ________________. ASSIGNOR further does hereby sell, assign and transfer to ASSIGNEE the entire right, title and interest, together with all rights of priority, in and to ASSIGNOR'S invention as described and/or claimed in any and all applications for patents based on the invention, including divisionals, continuations, renewals, substitutes and reissues thereof, and all rights of priority resulting from any of these patent applications, as well as all foreign counterparts and extensions thereof, together with all patents issuing on any of these applications for the full terms of all of the patents which may be granted on the invention. ASSIGNOR HEREBY AUTHORIZES ASSIGNEE to make applications for, to prosecute such applications, and to receive patents for the invention in the United States and any foreign countries, in ASSIGNEE's name. ASSIGNOR HEREBY PROMISES AND AGREES that ASSIGNOR will execute or procure any further necessary assurance of title to the invention and any patents which may issue on the invention. ASSIGNOR will, at any time, upon the request and without further consideration, but at the expense of ASSIGNEE, deliver any testimony in any legal proceedings and execute all papers and do all other things that may be necessary or desirable to perfect the title to the invention, or any patents which may be granted therefor, in ASSIGNEE, its successors, assigns, or other legal representatives. ASSIGNOR will, at any time, upon the request and at the expense of ASSIGNEE, execute any continuations, divisionals, reissues, or any other additional applications for patents for the invention or any part or parts thereof and any patents issuing thereon are hereby assigned to ASSIGNEE. AS...
Xxxxx, M. NATALEGAWA, Minister for Foreign Affairs For the Government of the Lao People's Democratic Republic: DR. XXXXXXXXX XXXXXXXXX, Deputy Prime Minister and Minister of Foreign Affairs For the Government of Malaysia: DATUK XXXXXXX RIOT ANAK JAEM, Deputy Minister of Foreign Affairs For the Government of the Union of Myanmar: XXXX XXX, Minister for Foreign Affairs For the Government of the Republic of the Philippines: XXXXXXX X. XXXXXX, Secretary of Foreign Affairs For the Government of the Republic of Singapore: XXXXXX XXXX-XXXX XXX, Minister for Foreign Affairs For the Government of the Kingdom of Thailand: XXXXX XXXXXXX, Minister of Foreign Affairs
Xxxxx, M. XXXXXXXXXX Minister for Foreign Affairs For the Government of the Lao People’s Democratic Republic:
Xxxxx, M. E., Xxxxxx, X.X., Xxxxxxxxxx, L.A., and X.X. Xxxxxxxx. 2018. Fragmentation alters home range and movements of the Dunes Sagebrush Lizard. Canadian Journal of Zoology 96(8):905-912.
Xxxxx, M. D., Ph.D. VIA FACSIMILE and U.S. MAIL February 06, 2004 Mxxxxxx Xxxxx President & CEO Z-KAT Corporation 2000 Xxxxx Xxxxxx Hollywood, Florida 33020 Re: Amendment Of 31 August License Agreement Dear Mxxxxxx: I am writing to confirm the details of an amendment to the agreement between Gxxxxx X. Xxxxx, M.D., Ph.D. (“Axxxx”) and Z-KAT, Inc. (“Z-KAT”) dated 31 August, 2001 (“License Agreement”). The changes are reflected for applicable sections and paragraphs, with text elimination and additions represented by strike-thrus and underline respectively.
Xxxxx, M. D., Ph.D. For Gxxxxx X. Xxxxx For Gxxxxx X. Xxxxx, M.D., Ph.D. For Z-KAT, Inc.: /s/ Gxxxxx Xxxxx /s/ Fxxxx XxXxxxx Gxxxxx X. Xxxxx, M.D., Ph.D. Fxxxx XxXxxxx, CFO 2/27/04 2/24/07 Date Date * A revised Schedule 1.10 will be prepared and attached to this amendment at a later date. [***] Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits the information subject to the confidentiality request. Omissions are designated as [***]. A complete version of this exhibit has been filed separately with the Securities and Exchange Commission. FIRST AMENDMENT TO LICENSE AGREEMENT THIS FIRST AMENDMENT TO LICENSE AGREEMENT (this “Amendment”) is entered into as of the 18th day of August, 2004 (the “Effective Date”), by and between Z-KAT, Inc., a Florida corporation having an office at 2000 Xxxxx Xxxxxx, Hollywood, Florida 33020 (“Z-KAT”), and Gxxxxx X. Xxxxx, M.D., Ph.D., with an address at 4000 Xxxxxx Xxxxx, Xxxxxxxxx, Xxxxxxxxx 00000 (“Dx. Xxxxx”).
Xxxxx, M. D. Entity shareholder sign here: ----------------------------------- (Print name of entity) By: -------------------------------- Name: ------------------------------ Title: ----------------------------- [Signature page to Amendment No. 1 to Restated Rights Agreement] ADDITIONAL EXISTING INVESTOR: Individual shareholder sign here: /s/ Xxxx X. Xxxxx ------------------------------ Name: Xxxx X. Xxxxx 7/11/99 ------------------------------ Entity shareholder sign here: ----------------------------------- (Print name of entity) By: -------------------------------- Name: ------------------------------ Title: ----------------------------- [Signature page to Amendment No. 1 to Restated Rights Agreement] ADDITIONAL EXISTING INVESTOR: Individual shareholder sign here: /s/ Xxxxxxx X. Xxxxxxx ------------------------------ Name: Xxxxxxx X. Xxxxxxx ------------------------------ Entity shareholder sign here: ----------------------------------- (Print name of entity) By: -------------------------------- Name: ------------------------------ Title: ----------------------------- [Signature page to Amendment No. 1 to Restated Rights Agreement] ADDITIONAL EXISTING INVESTOR: Individual shareholder sign here: /s/ Xxxxxx X. Xxxxxx ------------------------------ Name: Xxxxxx X. Xxxxxx ------------------------------ Entity shareholder sign here: ----------------------------------- (Print name of entity) By: -------------------------------- Name: ------------------------------ Title: ----------------------------- ADDITIONAL EXISTING INVESTOR: Individual shareholder sign here: ------------------------------ Name: ------------------------------ Entity shareholder sign here: ----------------------------------- (Print name of entity) By: /s/ Xxxx X. Xxxxx -------------------------------- Name: XXXX X. XXXXX ------------------------------ Title: ----------------------------- [Signature page to Amendment No. 1 to Restated Rights Agreement] ADDITIONAL EXISTING INVESTOR: Individual shareholder sign here: /s/ Xxxxxx X. Xxxxxxxx ------------------------------ Name: Xxxxxx X. Xxxxxxxx ------------------------------ Entity shareholder sign here: ----------------------------------- (Print name of entity) By: -------------------------------- Name: ------------------------------ Title: ----------------------------- [Signature page to Amendment No. 1 to Restated Rights Agreement] ADDITIONAL EXISTING INVESTOR: Individual shareholder sign here: /s/ Xxxxxx X. Xxxxx ------------------------------ Nam...
Xxxxx, M. T. Department of Electrical and Computer Engineering Faculty of Engineering International Islamic University Malaysia (IIUM) Prof. Dr. Xxxxx Xxxxx Xxxxxxx
Xxxxx, M. T.; Xxxxx, L.; Xxxxxx, X. X.; Xxxxxxxx, X. X.; Xxxxxxxxx, R.; Maikov, G. I.; Grinbom, G.; Xxxxxxx, X. X.; Xxxxxx, X. X.; Xxxxx, M. C.; Xxxxx, X. X.; Bonn, M.; Lifshitz, E.; Siebbeles, L. D. A. Nano Lett. 2011, 11, (4), 1623-1629.
